Full notification file
Member State to which the notification was sent
Date of acknowledgement from the Member State Competent Authority
Title of the Project
Ex vivo retroviral transduction of human T lymphocytes with melanoma-specific T cell receptor genes
Proposed period of release:
01/01/2011 to 01/10/2021
Name of the Institute(s) or Company(ies)
Netherlands Cancer Institute, Nederlands Kanker Instituut;
3. Is the same GMO release planned elsewhere in the Community?
Has the same GMPt been notified elsewhere by the same notifier?
GMO is a:
Identity of the GMO:
The GMO released into the environment are ex vivo retroviral transduced, autologous T cells that are administered intravenously to patients.
Used retrovirus for transduction: Gammaretrovirus, Moloney murine leukemia virus
Information relating to the recipient or parental organisms from wich the GMO is derived
Moloney murine leukemia virus
oncovirinae type C
European Commission administrative information
Consent given by the Member State Competent Authority: